The Evolution of Gene Therapy in the Treatment of Metabolic Liver Diseases.

Abstract excerpt

Monogenic metabolic disorders of hepatic origin number in the hundreds, and for many, liver transplantation remains the only cure. Liver-targeted gene therapy is an attractive treatment modality for many of these conditions, and there have been significant advances at both the preclinical and clinical stages. Viral vectors, including retroviruses, lentiviruses, adenovirus-based vectors, adeno-associated viruses...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Brain Diseases, Metabolic
• Share to CRISPR-Cas Systems
• Share to Disease Management